GlassScriptPhysician profile
Marc L Chaiken
NPI 1326032855
$730.12
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $85.23 · 2021: $266 · 2023: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $143.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $228.50 | 2021-2023 | Tisseel |
| Abbvie INC. | $147.91 | 2019-2021 | |
| Evofem Biosciences, INC. | $66.94 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.09 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $49.46 | 2019-2021 | |
| Therapeuticsmd, INC. | $27.91 | 2019 | |
| Allergan, INC. | $23.83 | 2019 | |
| Agile Therapeutics, INC. | $22.22 | 2021 | |
| Amgen INC. | $20.75 | 2019 | |
| Millicent US INC | $19.86 | 2019 | |
| Coopersurgical, INC. | $16.53 | 2019 | |
| Lupin INC. | $15.12 | 2019 | |
| Minerva Surgical, INC | $12.59 | 2021 | |
| Amag Pharmaceuticals, INC. | $12.07 | 2019 | |
| Duchesnay USA Incorporated | $11.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Chaiken listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.